Animal Models
Amyotrophic lateral sclerosis (ALS)
Alzheimer's disease
Anxiety/Depression
Emesis
Epilepsy
Fragile X Syndrome/Down's Syndrome
Mild Cognitive Impairment (MCI)
Pain and Inflammation
Parkinson's disease
Schizophrenia
Stroke
Traumatic Brain Injury
Tests and Assays
Affective Tests
Cognitive Tests
Morphology
Motor Tests
Neurochemistry
In Vitro Assays
Mouse Phenotyping
Addiction/Abuse Potential
Sleep EEG
Publications
Contact Us
What's New in CNS Drug Development
Alzheimer's Disease
Agreements News
Product News
R&D News
Analgesics/Anaesthetics
Agreements News
Product News
R&D News
Anti-Epileptics
Agreements News
Product News
R&D News
Antidepressants
Agreements News
Product News
R&D News
Anxiolytics/Sleep Disorders
Agreements News
Product News
R&D News
Cerebrovascular
Agreements News
Product News
R&D News
Drugs used in Nausea and Vertigo
Agreements News
Product News
R&D News
To receive these updates directly, fill out the information below and someone
will contact you regarding how you can receive CNS Drug News.
Name and E-mail address are
required fields.
Name:
Company Name:
Email Address:
Phone Number:
Other Areas of Interest
CNS
Cancer
Cardiovascular/Drugs & Devices
Diagnostics
Drug Delivery
Generics
Imaging
Orthopedics
Pharma Agreements